SlideShare a Scribd company logo
Patents and intellectual  property issues. Phil 133 – Ethics in Science San José State University
Who owns what’s in your head? You  own it, at least until you disclose it in some way. Depending upon how it gets into your head, it may become a trade secret.
Who owns what’s in your head? “ Work-for-hire”: Your employer  may  have a claim to own all that’s in your head, even what you think of on your own time. (Not in California, but in some other states – and California law may protect CA residents who are employed in states where the laws favor employers.)
Who owns what’s in your head? Not unusual for universities to make their employees, students sign patent agreements. If you discover something patentable, university gets the patent, not you. SJSU’s policy is more complicated … http://www.sjsu.edu/senate/f98-3.htm
Patents: what are they? Vandana Shiva notes three historical uses, not neatly separated in law: Patents for conquests Patents for inventions Patents for imports
Patents: what are they? Vandana Shiva notes three historical uses, not neatly separated in law: Patents for conquests Patents for inventions Patents for imports Used to establish colonies, import monopolies, not just reward invention.
Patents: what are they? A patent gives the holder a  limited right to a monopoly  (i.e., to exclude others from making, using, or selling the subject matter of the patented claims). After the term of the patent  (in U.S., 17 years from issue or 20 years from first filed application) , the  knowledge becomes a public good .
What can you patent? A process A machine A manufacture A composition of matter Any improvement thereof Recent court decision on BRCA1/BRCA1 patents.
What’s an improvement? Rogaine (minoxidil) was originally developed as an oral medication to treat high blood pressure. Hair growth was a side effect. Reformulated for topical use, filed for (and received) patent as hair growth treatment.
What’s an improvement? Prozac (fluoxetine) patented for treatment of depression. Near when patent was to expire (in 2001), Eli Lilly changed package insert and secured a new patent (under the name Sarafem) for fluoxetine as treatment of premenstrual dysphoric disorder (PMDD). Is new package insert improvement enough?
Who can claim patent rights? In the U.S.: First to invent ( not  file) One year grace period for filing Rest of world:  Absolute novelty (so no communication beforehand) No grace period
To be patentable, must be: NEW USEFUL UNOBVIOUS
To be patentable, must be: NEW How did a Texas company get a patent on Basmati rice (around for thousands of years)? USEFUL What about new allergy meds that are better than placebo but not existing meds? UNOBVIOUS To whom? (Software algorithms obvious to programmers but not Patent Office)
To be patentable: Need to be able to explain the process, machine, manufacture, composition of matter, or improvement thereof  in terms someone else can repeat .
To be patentable: Need to disclose “best mode” – can’t keep back the best of the invention for yourself. If you know it, it has to go into the patent application!
Witnessed and signed notebooks as legal documents: To document “best mode” as you know it when filing patent application. In establishing date of invention (which, under U.S. law, determines who gets the patent in case of conflict).
Vandana Shiva points out some problems: Do patent rights encourage innovation  – or theft? Patents issues on the basis that there is “no prior art”  in this jurisdiction .
Vandana Shiva points out some problems: Lack of uniform rules internationally. Push to enforce U.S. intellectual property laws in other jurisdictions (or face economic sanctions).
Vandana Shiva points out some problems: Biopiracy  – patenting products of local innovation (or of nature), then selling them back to the population that depends on them. In the social contract, what does this approach to patents do to increase the general welfare?
BRCA1/BRCA2 case Myriad Labs first sequenced these genes, associated with breast cancer. Patented genes, had monopoly on testing for them. Other labs argued that Myriad’s testing was not as advanced or accurate as what they had developed  but could not offer to patients, because of Myriad’s patents .
BRCA1/BRCA2 case Do patents for genes impede research by impeding sharing of information? Human Genome Project (significant federal funding) – aimed to make information about the genome freely available. Did HGP set groundwork for BRCA1/2 discovery?
BRCA1/BRCA2 case “ Myriad has sent cease and desist letters in connection with the patents-in-suit and … Myriad prohibits clinical testing of the  BRCA1/2  genes.” AMP vs. USPTO Opinion, p. 72.
BRCA1/BRCA2 case “ Myriad also does not permit researchers to tell patients involved in research the results of their  BRCA1/2  testing, leading physicians involved in breast cancer care ad research unable to meet their ethical obligations to provide genetic test results to research subjects, when requested.” AMP vs. USPTO Opinion, p. 72.
BRCA1/BRCA2 case Myriad argued that patents were essential to attract private money to develop clinical tests. Private money invested in BRCA1/BRCA2 commercialization significantly greater than public money invested in early stages of research.
BRCA1/BRCA2 case “ [P]roducts of nature do not constitute patentable subject matter absent a change that results in the creation of a fundamentally new product.” AMP vs. USPTO Opinion, p. 107.
What happened to the  norm of communism? If scientists are supposed to treat scientific knowledge as a shared resource that belongs to the whole community, doesn’t this conflict with the idea of “intellectual property”?
What happened to the  norm of communism? Secrecy required leading up to patent application (to establish “new” and “unobvious”). Choice between publishing or patenting. Use of knowledge during term of patent is restricted.
What’s the public’s stake? Economic growth -> good for everyone? How much did the patentable invention depend on resources funded with public moneys? Do patents convert public resources to private profits? Will knowledge provide actual benefit when patent expires?
What’s the public’s stake? How much does profit motive drive the direction of scientific research (and/or quality of scientific evidence generated)? Is this the best driver?

More Related Content

PPT
Lec15 Patents and Intellectual Property
PDF
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
PPTX
Montana IP Roadshow
PDF
Breast Cancer Patents Research - Myriad Genetics in US | Trastuzumab in India...
PDF
The New US Patent Law - From a Medical Device Perspective
PDF
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
PDF
2008 07 30 Legal Issues In Open Source
PPT
Present industry expectations from pharmacy students
Lec15 Patents and Intellectual Property
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
Montana IP Roadshow
Breast Cancer Patents Research - Myriad Genetics in US | Trastuzumab in India...
The New US Patent Law - From a Medical Device Perspective
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
2008 07 30 Legal Issues In Open Source
Present industry expectations from pharmacy students

Viewers also liked (6)

PDF
Intellectual Property Rights (IPR) in Engineering
PPT
PPTX
Ipr trips&trims
PPTX
Intellectual Property Rights (IPR)
PPTX
Intellectual property rights
PPTX
Intellectual Property Rights
Intellectual Property Rights (IPR) in Engineering
Ipr trips&trims
Intellectual Property Rights (IPR)
Intellectual property rights
Intellectual Property Rights
Ad

Similar to Patents and intellectual property (14)

DOCX
Gene patenting
PPTX
Basics of Life Science Patent Law
PPTX
Patent Overview in Novartis Case ppt
PDF
Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...
PDF
Feb Biocom panel
PPT
Oral+histology+on+the+web+br+mac pherson+%26+jg+tieman+anatomy+
PPT
Feisee Global Ip Challenges Washington Campus 2010
PPTX
New Patent System
PPT
016 patent infringement
PPT
BioEntrepreneurship: IP Strategy
DOCX
Overview on legal provisions on copyrights and patents of medicinal plants in...
PPTX
INTELLECTUAL PROPERTY RIGHTS IN AYURVEDA
PDF
Medical patents and how new instruments or medications
Gene patenting
Basics of Life Science Patent Law
Patent Overview in Novartis Case ppt
Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...
Feb Biocom panel
Oral+histology+on+the+web+br+mac pherson+%26+jg+tieman+anatomy+
Feisee Global Ip Challenges Washington Campus 2010
New Patent System
016 patent infringement
BioEntrepreneurship: IP Strategy
Overview on legal provisions on copyrights and patents of medicinal plants in...
INTELLECTUAL PROPERTY RIGHTS IN AYURVEDA
Medical patents and how new instruments or medications
Ad

More from Janet Stemwedel (20)

PPT
Climategate and scientific methodology
PPT
P160 Kuhn and his Critics
PPT
P160 Duhem and Quine
PPT
P160 Hempel, Hume, Deduction, and Induction
PPT
Lect10 Human Subjects: History
PPT
Lect11 Human Subjects: Regulations
PPT
Lec12 Human Subjects:Global Issues
PPT
Lec13 Scientific Papers and Communications
PPT
Lec 14 Authorship Issues
PPT
Lec16 International Strategies for Scientific Dialogue
PPT
Explanation classroomversion
PPT
P160 antirealismclassroomversion
PPT
P160 naturalismclassroomlect
PPT
Feminist Critiques of Science
PPT
Indirect-table Analysis
PPT
Truth table analysis
PPT
Translating English to Propositional Logic
PPT
P160 Kuhn classroom Lecture 2
PPT
Propositional logic
PPT
Kuhn: Paradigms and Normal Science
Climategate and scientific methodology
P160 Kuhn and his Critics
P160 Duhem and Quine
P160 Hempel, Hume, Deduction, and Induction
Lect10 Human Subjects: History
Lect11 Human Subjects: Regulations
Lec12 Human Subjects:Global Issues
Lec13 Scientific Papers and Communications
Lec 14 Authorship Issues
Lec16 International Strategies for Scientific Dialogue
Explanation classroomversion
P160 antirealismclassroomversion
P160 naturalismclassroomlect
Feminist Critiques of Science
Indirect-table Analysis
Truth table analysis
Translating English to Propositional Logic
P160 Kuhn classroom Lecture 2
Propositional logic
Kuhn: Paradigms and Normal Science

Recently uploaded (20)

PDF
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
PDF
Supply Chain Operations Speaking Notes -ICLT Program
PPTX
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
PDF
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...
PDF
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
PPTX
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
PDF
Anesthesia in Laparoscopic Surgery in India
PPTX
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
PPTX
Cell Types and Its function , kingdom of life
PDF
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
PDF
Pre independence Education in Inndia.pdf
PDF
Module 4: Burden of Disease Tutorial Slides S2 2025
PPTX
Final Presentation General Medicine 03-08-2024.pptx
PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PPTX
PPH.pptx obstetrics and gynecology in nursing
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
PPTX
Renaissance Architecture: A Journey from Faith to Humanism
PDF
Basic Mud Logging Guide for educational purpose
PDF
O7-L3 Supply Chain Operations - ICLT Program
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
Supply Chain Operations Speaking Notes -ICLT Program
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...
Mark Klimek Lecture Notes_240423 revision books _173037.pdf
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
Anesthesia in Laparoscopic Surgery in India
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
Cell Types and Its function , kingdom of life
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
Pre independence Education in Inndia.pdf
Module 4: Burden of Disease Tutorial Slides S2 2025
Final Presentation General Medicine 03-08-2024.pptx
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PPH.pptx obstetrics and gynecology in nursing
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
Renaissance Architecture: A Journey from Faith to Humanism
Basic Mud Logging Guide for educational purpose
O7-L3 Supply Chain Operations - ICLT Program

Patents and intellectual property

  • 1. Patents and intellectual property issues. Phil 133 – Ethics in Science San José State University
  • 2. Who owns what’s in your head? You own it, at least until you disclose it in some way. Depending upon how it gets into your head, it may become a trade secret.
  • 3. Who owns what’s in your head? “ Work-for-hire”: Your employer may have a claim to own all that’s in your head, even what you think of on your own time. (Not in California, but in some other states – and California law may protect CA residents who are employed in states where the laws favor employers.)
  • 4. Who owns what’s in your head? Not unusual for universities to make their employees, students sign patent agreements. If you discover something patentable, university gets the patent, not you. SJSU’s policy is more complicated … http://www.sjsu.edu/senate/f98-3.htm
  • 5. Patents: what are they? Vandana Shiva notes three historical uses, not neatly separated in law: Patents for conquests Patents for inventions Patents for imports
  • 6. Patents: what are they? Vandana Shiva notes three historical uses, not neatly separated in law: Patents for conquests Patents for inventions Patents for imports Used to establish colonies, import monopolies, not just reward invention.
  • 7. Patents: what are they? A patent gives the holder a limited right to a monopoly (i.e., to exclude others from making, using, or selling the subject matter of the patented claims). After the term of the patent (in U.S., 17 years from issue or 20 years from first filed application) , the knowledge becomes a public good .
  • 8. What can you patent? A process A machine A manufacture A composition of matter Any improvement thereof Recent court decision on BRCA1/BRCA1 patents.
  • 9. What’s an improvement? Rogaine (minoxidil) was originally developed as an oral medication to treat high blood pressure. Hair growth was a side effect. Reformulated for topical use, filed for (and received) patent as hair growth treatment.
  • 10. What’s an improvement? Prozac (fluoxetine) patented for treatment of depression. Near when patent was to expire (in 2001), Eli Lilly changed package insert and secured a new patent (under the name Sarafem) for fluoxetine as treatment of premenstrual dysphoric disorder (PMDD). Is new package insert improvement enough?
  • 11. Who can claim patent rights? In the U.S.: First to invent ( not file) One year grace period for filing Rest of world: Absolute novelty (so no communication beforehand) No grace period
  • 12. To be patentable, must be: NEW USEFUL UNOBVIOUS
  • 13. To be patentable, must be: NEW How did a Texas company get a patent on Basmati rice (around for thousands of years)? USEFUL What about new allergy meds that are better than placebo but not existing meds? UNOBVIOUS To whom? (Software algorithms obvious to programmers but not Patent Office)
  • 14. To be patentable: Need to be able to explain the process, machine, manufacture, composition of matter, or improvement thereof in terms someone else can repeat .
  • 15. To be patentable: Need to disclose “best mode” – can’t keep back the best of the invention for yourself. If you know it, it has to go into the patent application!
  • 16. Witnessed and signed notebooks as legal documents: To document “best mode” as you know it when filing patent application. In establishing date of invention (which, under U.S. law, determines who gets the patent in case of conflict).
  • 17. Vandana Shiva points out some problems: Do patent rights encourage innovation – or theft? Patents issues on the basis that there is “no prior art” in this jurisdiction .
  • 18. Vandana Shiva points out some problems: Lack of uniform rules internationally. Push to enforce U.S. intellectual property laws in other jurisdictions (or face economic sanctions).
  • 19. Vandana Shiva points out some problems: Biopiracy – patenting products of local innovation (or of nature), then selling them back to the population that depends on them. In the social contract, what does this approach to patents do to increase the general welfare?
  • 20. BRCA1/BRCA2 case Myriad Labs first sequenced these genes, associated with breast cancer. Patented genes, had monopoly on testing for them. Other labs argued that Myriad’s testing was not as advanced or accurate as what they had developed but could not offer to patients, because of Myriad’s patents .
  • 21. BRCA1/BRCA2 case Do patents for genes impede research by impeding sharing of information? Human Genome Project (significant federal funding) – aimed to make information about the genome freely available. Did HGP set groundwork for BRCA1/2 discovery?
  • 22. BRCA1/BRCA2 case “ Myriad has sent cease and desist letters in connection with the patents-in-suit and … Myriad prohibits clinical testing of the BRCA1/2 genes.” AMP vs. USPTO Opinion, p. 72.
  • 23. BRCA1/BRCA2 case “ Myriad also does not permit researchers to tell patients involved in research the results of their BRCA1/2 testing, leading physicians involved in breast cancer care ad research unable to meet their ethical obligations to provide genetic test results to research subjects, when requested.” AMP vs. USPTO Opinion, p. 72.
  • 24. BRCA1/BRCA2 case Myriad argued that patents were essential to attract private money to develop clinical tests. Private money invested in BRCA1/BRCA2 commercialization significantly greater than public money invested in early stages of research.
  • 25. BRCA1/BRCA2 case “ [P]roducts of nature do not constitute patentable subject matter absent a change that results in the creation of a fundamentally new product.” AMP vs. USPTO Opinion, p. 107.
  • 26. What happened to the norm of communism? If scientists are supposed to treat scientific knowledge as a shared resource that belongs to the whole community, doesn’t this conflict with the idea of “intellectual property”?
  • 27. What happened to the norm of communism? Secrecy required leading up to patent application (to establish “new” and “unobvious”). Choice between publishing or patenting. Use of knowledge during term of patent is restricted.
  • 28. What’s the public’s stake? Economic growth -> good for everyone? How much did the patentable invention depend on resources funded with public moneys? Do patents convert public resources to private profits? Will knowledge provide actual benefit when patent expires?
  • 29. What’s the public’s stake? How much does profit motive drive the direction of scientific research (and/or quality of scientific evidence generated)? Is this the best driver?